Validation pour Ingenuity287

vers la météo de la validation par utilisateur

Ingenuity287

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 2 - PMID ?

In pancreatic islets from SP , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of SP NODE mRNA that is increased by constitutively active mutant SREBP 1c [NODE] protein ( C terminal truncation 404 End ) .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  +------COMP:N-N(from)------+       +-------------OBJ:V-N------------+                      |                             |                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+---SUBJ:V-N---+               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |              |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,aminoimidazole)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,islet)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-N (truncation,terminal)
MOD_ATT:N-N (end,truncation)

Analyse 1

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  +------COMP:N-N(from)------+       +-------------OBJ:V-N------------+                      |              +---SUBJ:V-N---+                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+SUBJ:V-N+     |               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |        |     |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,aminoimidazole)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,islet)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-N (truncation,terminal)
MOD_ATT:N-N (end,truncation)

Analyse 2

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  |                          |       +-------------OBJ:V-N------------+                      |                             |                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+---SUBJ:V-N---+               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |              |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,islet)
COMP:V-N(from) (increase,aminoimidazole)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-N (truncation,terminal)
MOD_ATT:N-N (end,truncation)

Analyse 3

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  |                          |       +-------------OBJ:V-N------------+                      |              +---SUBJ:V-N---+                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+SUBJ:V-N+     |               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |        |     |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,islet)
COMP:V-N(from) (increase,aminoimidazole)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-N (truncation,terminal)
MOD_ATT:N-N (end,truncation)

Analyse 4

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  +------COMP:N-N(from)------+       +-------------OBJ:V-N------------+                      |                             |                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+---SUBJ:V-N---+               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |              |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,aminoimidazole)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,islet)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-ADJ (truncation,terminal)
MOD_ATT:N-N (end,truncation)

Analyse 5

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  +------COMP:N-N(from)------+       +-------------OBJ:V-N------------+                      |              +---SUBJ:V-N---+                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+SUBJ:V-N+     |               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |        |     |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,aminoimidazole)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,islet)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-ADJ (truncation,terminal)
MOD_ATT:N-N (end,truncation)

Analyse 6

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  |                          |       +-------------OBJ:V-N------------+                      |                             |                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+---SUBJ:V-N---+               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |              |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,islet)
COMP:V-N(from) (increase,aminoimidazole)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-ADJ (truncation,terminal)
MOD_ATT:N-N (end,truncation)

Analyse 7

                  +------------------------------------------------------COMP:V-N(In)------------------------------------------------------+                                                                                                    
                  |                          +----------------------------------------COMP:V-N(from)---------------------------------------+                                                                                                    
                  |                          +----------------------------OBJ:V-N----------------------------+                             +---------------------------OBJ:V-N--------------------------+                                       
                  |                          |       +------------------------SUBJ:V-N-----------------------+                             +--------------COMP:V-N(by)-------------+                    +--------------APPOS--------------+     
                  |                          |       +-------------OBJ:V-N------------+                      |              +---SUBJ:V-N---+                          +MOD_ATT:N-AD+    +-MOD_ATT:N-ADJ-+      +--MOD_ATT:N-N--+          |     
         +MOD_ATT:+           +-MOD_ATT:N-ADJ+       |      +-MOD_ATT:N-N-+--SUBJ:V-N-+--OBJ:V-N-+MOD_PO+    |       +MOD_AT+SUBJ:V-N+     |               +MOD:ADJ-AD+      +MOD_A+    |      +MOD_ATT:+      |     +MOD_ATT:N+MOD_ATT:N-+     
         |        |           |              |       |      |             |           |          |      |    |       |      |        |     |               |          |      |     |    |      |        |      |     |         |          |     
 In pancreatic islets from __SP__ , 5 aminoimidazole 4 carboxamide ribonucleoside decreases expression of __SP__ __NODE__ mRNA that is increased by constitutively active mutant SREBP 1c [__NODE__] protein ( C terminal truncation 404 End ) .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (ribonucleoside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,ribonucleoside)
OBJ:V-N (decrease,expression)
MOD_POST:N-ADJ (expression,of)
OBJ:V-N (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,islet)
COMP:V-N(from) (increase,aminoimidazole)
SUBJ:V-N (increase,mRNA)
COMP:V-N(by) (increase,SREBP)
OBJ:V-N (increase,protein)
MOD:ADJ-ADV (active,constitutively)
MOD_ATT:N-ADJ (SREBP,active)
MOD_ATT:N-ADJ (SREBP,mutant)
MOD_ATT:N-ADJ (protein,1c)
MOD_ATT:N-N (protein,[__NODE__])
APPOS (protein,end)
MOD_ATT:N-N (truncation,C)
MOD_ATT:N-ADJ (truncation,terminal)
MOD_ATT:N-N (end,truncation)